VistaGen Therapeutics
VTGN
VTGN
48 hedge funds and large institutions have $39M invested in VistaGen Therapeutics in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 20 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
40% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 20
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
Holders
48
Holding in Top 10
–
Calls
$29K
Puts
$4K
Top Buyers
| 1 | +$1.31M | |
| 2 | +$748K | |
| 3 | +$389K | |
| 4 |
DP
Diadema Partners
Morristown,
New Jersey
|
+$309K |
| 5 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$139K |
Top Sellers
| 1 | -$574K | |
| 2 | -$318K | |
| 3 | -$266K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$230K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$150K |